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ABSTRACT
Hospital and Meat Associated Staphylococcus aureus
and Their Biofilm Characteristics
Trevor Michael Wienclaw
Department of Microbiology and Molecular Biology, BYU
Master of Science
Biofilm phenotypes were studied in 32 Staphylococcus aureus strains isolated from storebought meats and 22 from diseased patients in hospitals. Of the meat-associated strains, 21 were
methicillin-resistant Staphylococcus aureus (MRSA) and 11 were methicillin-susceptible
Staphylococcus aureus (MSSA). The hospital-associated strains included 15 MRSAs and 7
MSSAs. We studied the robustness and composition of the biofilms produced by these strains.
We found that on average hospital-associated strains form more robust biofilms than meat
associated strains. The model often used to describe S. aureus biofilm composition includes two
biofilm types defined by the presence or absence of polysaccharide intercellular adhesin (PIA),
PIA-dependent and PIA-independent respectively. In this model, PIA-independent biofilms are
structurally reliant on proteins and extracellular DNA (eDNA) and PIA-dependent are
structurally reliant on polysaccharides. Enzymatic degradation of the extracellular matrix can
reveal which compounds are essential for the structural integrity of the biofilm, and by this
model PIA-independent biofilms should be susceptible to both DNase and proteinase K. We
found that hospital-associated strains are, on average, more susceptible to degradation by
proteinase K. Interestingly, hospital-associated strains are less susceptible to degradation by
DNase than meat-associated strains. Finding that proteinase K and DNase susceptibility for these
strains are not linked gives evidence to support the idea that S. aureus biofilm composition can
vary greatly from strain to strain and that the PIA-dependent and PIA-independent dichotomy of
the standard model may be insufficient to describe the variety of S. aureus biofilm composition
and may only apply to the extremes of the spectrum. Additionally, we saw no relationship
between MRSA or MSSA strains and biofilm robustness, proteinase K degradation, or DNase
degradation. Differences in biofilm characteristics between hospital-associated and meatassociated strains reinforce previous findings that these populations are genetically distinct.

Keywords: staphylococcus aureus, s. aureus, biofilm, methicillin resistant styphylococcus aureus,
hospital, meat, food safety
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Introduction

Staphylococcus aureus is a common commensal bacterium and opportunistic pathogen. It
establishes long-term colonization in 20-30% of the human population, and transient
colonization in 60% [1-3]. Though carriage is usually asymptomatic, infection can cause a wide
range of diseases including skin and soft tissue infection, bacteremia, pneumonia, and
endocarditis [2, 4-6]. S. aureus is possibly the most common cause of food poisoning and the
leading cause of death of any infectious agent in the United States and is a leading cause of
hospital-associated infection throughout the developed world, being second only to Clostridium
difficile in the United States [7-9]. Additionally, S. aureus infection rates have increased in
recent decades, including both hospital and community acquired infections [10]. For soft-tissue
infections alone there were an estimated 48.1 cases per 1,000 population in 2005 [10]. Infections
associated with S. aureus can have mortality rates as high as 25% [11].
S. aureus can carry a variety of virulence factors including leukocidins, hemolysins,
enterotoxins, the super antigen TSST-1, protein A, and biofilm genes [6, 12-15]. Antibiotic
resistant strains of S. aureus have been known since shortly after the introduction of penicillin
[2]. These first resistant strains produced a penicillinase and were still susceptible to the secondgeneration penicillins, such as methicillin, that were introduced in the early 1960s. However,
resistance to these new drugs was reported within one year [2, 8]. These strains of methicillinresistant Staphylococcus aureus, or MRSA, had acquired the gene mecA, an antibiotic-resistant
transpeptidase which allows cell wall synthesis to carry on in the presence of beta-lactam
antibiotics [8, 16, 17]. Though methicillin is no longer used clinically the term MRSA is still
used to describe any S. aureus strain which carries mecA. MRSA, while originally only found in
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hospitals, was found to be common in the community outside of hospitals in the 1980s, leading
to the terms hospital acquired MRSA (HA-MRSA) and community acquired MRSA (CAMRSA) to differentiate these genetically distinct families of MRSA [4, 7]. The antibiotic
vancomycin is used to treat MRSA infections as a last resort, though vancomycin-resistant SA
(VRSA) strains have been reported in recent years [18, 19]. Most clinical S. aureus infections are
transmitted from person-to-person contact, in both hospital-acquired and community-acquired
transmissions [4, 20, 21]. However, S. aureus can also be transmitted to humans from direct
contact with living livestock or through exposure to contaminated meats [22-25]. In the United
States, SA can be isolated from retail meat products at rates between 20% and 50% depending on
the study location, and type of meat tested [26, 27].

Genetics of S. aureus antibiotic resistance
The antibiotic resistance gene of MRSA, mecA, was acquired as part of a mobile genetic
element called the staphylococcal cassette chromosome mec (SCCmec). SCCmec is thought to
have originated from a non-staphylococcal source, and twelve SCCmec variations have been
described [28-30]. In addition to mecA the SCCmec contains a number of genes of unknown
function and what is known as the ccr gene complex, ccrAB and/or ccrC, all of which have roles
in promoting site-specific recombination [28]. The gene mecA encodes the membrane-bound
transpeptidase penicillin-binding protein 2A (PBP2a) which catalyzes peptidoglycan crosslinking
during cell-wall synthesis [16]. This class of enzymes, which were named for their affinity for
penicillin, are inhibited when bound by beta-lactams. PBP2a, however, has a uniquely lower
affinity for beta-lactams, allowing PBP2a to carry on cell wall synthesis when the activity of the
four native SA penicillin-binding proteins is blocked [29, 31].
2

Some SCCmec types have a regulatory system in place consisting of a transcriptional
repressor, a sensor-inducer, and an anti-repressor to control the expression of mecA, though most
clinical MRSA strains appear to have a non-functional regulatory system [32]. High constitutive
expression appears to be necessary to give the beta-lactam resistant phenotype associated with
MRSA. Because of the slow response time of a functional regulatory system, strains without
constitutive expression often appear susceptible to oxacillin in testing, even though they have a
functional mecA gene [32, 33]. The varied levels of beta-lactam resistance among MRSA strains
is due to varied levels of mecA expression [5]. MRSAs can be classified into two categories
based on resistance levels – heterogeneously resistant (HeR) and homogeneously resistant
(HoR). HeR strains are those able to grow in oxacillin concentrations between 2 and 100 μg/ml
while HoR strains can grow in oxacillin concentrations in excess of 100 μg/ml [5].

Biofilm formation
One of the key virulence factors of S. aureus is its ability to form biofilms. S. aureus
biofilms are sticky conglomerations of cells surrounded by an extracellular matrix which provide
protection from mechanical removal of cells, host immune responses (both innate and adaptive),
and antibiotics, giving as much as a 6-log increase in cell viability over planktonic cells
following antibiotic challenge [34-36]. Additionally, S. aureus biofilm formation greatly
increases the occurrence of horizontal gene transfer, contributing to the spread of antibiotic
resistance [37]. S. aureus biofilms are a major concern in hospitals, not just for the danger of
infection of damaged host tissue, but also because of the ability of S. aureus to form biofilms on
implanted medical devices such as catheters, pacemakers, artificial heart valves, intravascular
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lines, and joint replacements [38]. Colonization of such devices can lead serious, chronic
infections that are difficult to treat [11, 34].
S. aureus biofilm formation is a highly organized process allowing for the formation of
complex three-dimensional structures with channels that allow for the flow of nutrients to cells
located deeper within the matrix [34, 39]. The biofilms have tightly regulated growth patterns
that regulate attachment to a surface, the growth and expansion of the biofilm, and detachment
and spread [34, 36]. These processes are regulated through quorum sensing, allowing the optimal
cell density to be maintained by regulating the dispersal of cells for spread to new areas. During
the growth phase some cells will even undergo an apparently altruistic autolysis to provide
neighboring cells with the materials necessary to construct the extracellular matrix (such as
DNA, for example) [39, 40].
Though there are some general characteristics that connect most S. aureus biofilms, the
composition of the extracellular matrix from strain to strain can be drastically different [38, 41,
42]. In general, these varied extracellular matrix compositions are categorized into two classes
based upon the presence of polysaccharide intercellular adhesin (PIA), PIA-dependent and PIAindependent [5, 38]. The biofilm class of any particular strain can be determined by a simple test.
Biofilms are grown in 96 well plates and then treated with proteinase K which degrades proteins
or sodium meta-periodate which oxidizes polysaccharide linkages. PIA-dependent biofilms are
unaffected by proteinase K treatment and dispersed by sodium meta-periodate treatment, while
PIA-independent biofilms are dispersed by proteinase K treatment and unaffected by sodium
meta-periodate [41, 42]. While there have been thorough studies of the composition and genes
associated with each class of biofilm [43-45] only an overview of the major components will be
given here.
4

PIA-dependent
PIA-dependent biofilms are the “classic” biofilm type, they were the first studied and are
what are usually described when talking about the average S. aureus strain [11, 44, 46]. Their
extracellular matrix consists primarily of PIA, built from the polysaccharide poly-β(1-6)-Nacetylglucosamine (PNAG), but also contains a variety of proteins, extracellular DNA (Edna),
and amyloid fibrils (see fig 1) [44]. Many cytoplasmic proteins and genomic DNA become
associated with the extracellular matrix as cells undergo autolysis. This altruistic act of some
cells, which is triggered through quorum sensing, provides the raw materials necessary to form
the biofilm [34, 39, 40]. The eDNA, while not necessary for the structural integrity of PIAdependent biofilms, is important for the formation of amyloid fibrils from phenol-soluble
modulins, which contribute to biofilm stability [42, 47]. The primary component of PIAdependent biofilms is, of course, PIA. This polysaccharide is produced and assembled into the
extracellular matrix by the products of the icaADBC operon (see figure 3 B). icaA is an Nacetylglucosaminyltransferase that synthesizes PIA; icaD produces a product that, while not fully
understood, is known to increases the efficiency of icaA; icaB produces an N-deacetylase which
partially deacetylates PIA; and icaC is involved in the exportation of PIA to the cell surface [44,
48]. While several genes are known to influence the production of PIA the best characterized is
icaR, a divergently transcribed repressor of the ica operon located just upstream of the icaA gene
[48-50].
PIA-independent
PIA-independent biofilms are most notably characterized by the lack of PIA, instead,
these biofilms rely solely on extracellular proteins and eDNA for their structural integrity, a
difference which can even be seen by electron microscopy (see Fig. 1) [38, 41]. The reliance of
5

eDNA in PIA-independent biofilms makes the agr quorum-sensing system, which triggers
autolysis, vital in biofilm formation [40, 51]. Once DNA is released it is thought to interact with
cell surface proteins to bind cells one to another [38]. The primary proteins involved in the PIAindependent biofilm type are the membrane-bound fibronectin-binding proteins FnBPA and
FnBPB [40]. The function of these proteins in biofilm formation appears to be redundant as
either may be knocked out and biofilms will continue to form normally [52]. Other membranebound proteins, such as protein A and SasG have been shown to be involved in PIA-independent
biofilm formation, though their specific functions and possible interactions with eDNA have yet
to be studied [38, 43]. Extracellular proteases are of crucial importance for PIA-independent
biofilms. Protease production is limited during biofilm maturation and increased, allowing for
degradation of the extracellular matrix, for biofilm dispersal [35, 51, 53]

6

Figure 1 – S. aureus biofilm phenotypes
A: A simplified representation of PIA-dependent and PIA-independent biofilm structures are shown. The
primary structural element of PIA-dependent biofilms is PIA whereas PIA-independent biofilms are
structurally dependent upon the interaction of surface proteins and extracellular DNA (eDNA). B: Shown
are scanning electron micrographs of PIA-dependent (strain SH1000) and PIA-independent biofilms
(strain BH1CC). The obvious difference is the presence of PIA which largely obscures the cells of the
PIA-dependent strain. Electron micrographs by McCarthy et al. [38].

7

The link between antibiotic-resistance and biofilm type
It has been observed that MRSA strains tend to produce a PIA-independent biofilm type
while methicillin-susceptible SA (MSSA) tend to produce PIA-dependent biofilms [5, 38, 41, 43,
54]. This trend is typically described in the context of HoR MRSA strains [5, 38]. In one study
by Pozzi et al, MSSA cells producing a PIA-dependent biofilm were transformed with a plasmid
containing mecA. These cells were then put through a selection to isolate a HoR strain. A
complete shift in biofilm type from PIA-dependent to PIA-independent was observed and icaA
expression was drastically reduced. The plasmid was then cured (turning the strain back into
MSSA) and the strain returned to a PIA-dependent biofilm type and icaA expression returned to
normal. How this shift in biofilm type is accomplished is unknown. PBP2a is membrane-bound
and is not known to have any direct effect on transcription, yet mutation of its active site
abolishes the effects on ica transcription. Furthermore, the repression of the ica operon was
found to be icaR independent (see figure 2). It has been suggested that a change in cell wall
architecture through the action of PBP2a may be responsible for this drastic shift in biofilm
composition, yet this is still uncertain and more research into these mechanisms has yet to be
done [5, 38].

Project 1 – Mutagenesis to find genetic influencers of ica expression in response to PBP2a
production

Description
This first project was aimed at better understanding the relationship between mecA and
ica operon expression. Due to technical difficulties in cloning a reporter plasmid, this project was
8

A
B

C

Figure 2 – Expression of biofilm genes
Figures and data by Pozzi et al. demonstrating the relationships between the expression of mecA, icaA,
and icaR [4] A: Western blot analysis of PBP2a levels, the product of mecA. 8325-4 is a MSSA strain
with no copy of mecA. When it is added by the plasmid pmecA it becomes an HeR MRSA. When selected
for a highly resistant HoR mutant, mecA expression dramatically increased. B: Analysis of icaA
expression by qPCR demonstrating the effect of increased mecA expression on icaA expression. 8325-4
(MSSA), 8325-4 pmecA HeR (HeR MRSA), 8325-4 pmecA HoR (HoR MRSA), and the HoR variant
cured of the plasmid. From this we can see that icaA expression drops in response to increased mecA
expression and returns to normal when mecA expression is abolished by curing the plasmid. C:
Measurement of icaR expression of the same strains, leading us to believe that ica operon modulation in
response to mecA is icaR independent.
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put on hold while we investigated the observations described in project 2. Though it is yet to be
completed, the experimental design along with all of this projects findings are described here.
As can be seen in Figure 2, high mecA expression, associated with homogeneously
resistant MRSA strains, is accompanied by a drop in ica operon expression. This relationship
appears to be due to some unknown repressor, as the normal repressor for this system, icaR, had
no significant change in expression in response to mecA expression [5]. Furthermore, the activity
of PBP2a was found to be necessary to cause a change in ica expression and a shift in biofilm
type. Mutation of the PBP2a active site abolished any effect on biofilm phenotype or gene
expression [5].
The goal of this project was to find any other genes besides mecA that were responsible
for the observed drop in ica expression. These genes might include a repressor directly
responsible for the repression of the polysaccharide producing ica genes and any genes involved
in signal transduction. The hypothesis of this project was that an unknown repressor, or repressor
not known to act upon the ica operon, was responsible for repressing ica expression in response
to mecA expression and causing the PIA-independent biofilm phenotype. Alternatively, the same
phenotype could be caused by the repression of an activator of the ica operon. The relationship
between these genes could be indirect. Changes in cell wall structure resulting from differences
in the enzymatic action of PBP2a from the four penicillin-binding proteins native to S. aureus
might be the root cause of the observed phenotype. Alterations in cell wall structure could cause
changes in cellular processes and alter gene expression.
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Experimental approach
With nothing known about our target, and so many possibilities as to its function and
identity, we elected to employ a forward genetic screen. We would use a chemical mutagen to
disrupt genes at random and screen for mutants with altered ica expression. To be able to easily
observe changes in ica expression we would create a reporter plasmid with gfp under control of
the ica promoter. MRSA mutants with restored ica expression would appear green. These would
be collected after observing colonies on plates, or possibly by FACS, and sequenced. Point
mutations would be plotted to find mutation “hot spots” with higher mutation rates than average,
indicating genes which, when mutated, lead to an increase in ica expression. Each of these genes
would be investigated as possibly playing a role in the mecA-dependent repression of the ica
operon.

Strains
The wild type strain used in this study is JE2. JE2 is a MRSA strain derived from the
commonly used, highly-characterized USA300 LAC. JE2 has been cured of two plasmids found
in USA300 LAC, one encoding macrolide resistance and a second cryptic plasmid. JE2 carries
the mecA gene for beta-lactam resistance, is ica positive, and produces a PIA-independent
biofilm type [55]. We would also be using the strain JE2 mecA::mar which is a transposon
mutant of JE2 with a single insertion in the mecA gene [56]. We confirmed experimentally that
this transposon insertion abolishes beta-lactam resistance and results in the reversion to the PIAdependent biofilm type. These strains were chosen because they are genetically identical except
for the transposon insertion.
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We created JE2 HoR, a highly-resistant variant of JE2 created through selection on agar
with high concentrations of oxacillin. In HoR strains, spontaneous mutations lead to increased
mecA expression and higher resistance [5, 57, 58]. JE2 HoR can grow at concentrations of 100
μg/ml oxacillin, is slower growing than JE2, and exhibits a PIA-independent biofilm phenotype.

Assessment of biofilm phenotype
Biofilm phenotype was assessed by staining biofilms grown in 96-well plates. Biofilms
were grown in the wells for 24 hours with no shaking, washed, and treated with proteinase K,
Dnase, or sodium meta-periodate and stained with crystal violet. The crystal violet was then
eluted and the absorbance at 595 nm was taken as a quantitative measure of the biofilm mass
accumulated within the well. Crystal violet, which is positively charged, will stain negatively
charged molecules within the cells and extracellular matrix such as proteins and DNA. Biofilm
dispersal by treatment with proteinase K or Dnase indicates a PIA-independent phenotype and
dispersal by sodium meta-periodate indicates a PIA-dependent phenotype.
The theory behind this assay is that without PIA production the biofilm is structurally
dependent on extracellular DNA and proteins for its structural integrity and is able to be
dispersed by proteinase K or Dnase treatment. If PIA is produced, proteinase K and Dnase will
not be able to disperse the biofilm, but it will instead be susceptible to sodium meta-periodate
treatment which oxidizes polysaccharides.
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Creation of ica reporter plasmid
At this point in the project we encountered difficulties which led to this project being put
on hold in favor of pursuing other, more fruitful experiments. What follows is the planned
approach for the rest of this project. An ica reporter plasmid is to be used to easily assess ica
expression levels. Determination of biofilm type by the plate based method is long and laborintensive. A reporter plasmid allows visual assessment ica expression levels, and thereby biofilm
phenotype, of a large number of mutant cells. This reporter is to be composed of a fusion of the
ica promoter region and gfp created by overlap-extension PCR. This included 884 bp upstream
of the icaA start codon, a region containing the entire ica promoter region as well as the entire
icaR gene. We want to be sure and include any elements that may have an effect on ica
transcription. The first 5 codons of icaA will be included, but will be truncated by an in-frame
stop codon. A Shine-Dalgarno sequence and spacer sequence taken from the EF-TU gene of S.
aureus, selected for its high expression, was used to ensure efficient translation. The ATG start
codon of EF-TU is the precise location where we would fuse gfp to the ica promotor region (see
figure 3 C). This fusion was designed with EcoRI and KpnI restriction sites on the ends for the
insertion into the MCS of the plasmid pJB38 (see figure 3 A and C). This plasmid confers
ampicillin resistance in E. coli, chloramphenicol resistance in S. aureus, and is temperature
sensitive in S. aureus (requiring any S. aureus strains carrying the plasmid to be grown at 30°C)
[59].
This plasmid is to be assembled in vitro from purified plasmid and the overlap-extension PCR
product and transformed into E. coli for replication. Because DNA from E. coli will be restricted
when introduced into S. aureus the plasmid would need to be passed through the intermediate
strain, RN4220, a restriction-negative S. aureus to acquire proper DNA methylation before
13

transformation into the final recipient by electroporation [60]. All three of our experimental
strains (JE2, JE2 mecA::mar, and JE2 HoR) will be transformed to serve as baselines of ica
expression. JE2 mecA::mar would indicate normal ica expression, and JE2 and JE2 HoR would
indicate reduced ica expression. This would also aid us in deciding whether JE2 or JE2 HoR
should be used for the mutagenesis part of this study. If ica expression in JE2 is drastically
different from JE2 mecA::mar we would use JE2, if not, we would use JE2 HoR. These baseline
levels of fluorescence would be measured and established by flow cytometry.

14

A

B
C

D

EcoRI

Figure 3 – Genetic maps of the cloning portion of project 1
A: Map and details of the plasmid pJB38, the backbone for ica reporter constructs. B: Map of the ica
operon in its native state including the repressor of this system, icaR, as well as the genes responsible for
PIA production, icaA, icaD, icaB, and icaC. C: Map of the insert created by overlap extension PCR for
the ica-gfp construct. D: Map of the two inserts (shown together at the SmaI restriction site) for the icalacZ construct.
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Chemical Mutagenesis
For mutagenesis we will use the mutagen ethyl methanesulfonate (EMS). EMS is a
mutagenic compound which introduces random mutations through guanine alkylation, forming
O-6 ethylguanine. During DNA replication, the damage becomes a permanent mutation when
thymine is inserted across from the O-6 ethylguanine instead of cytosine [61]. EMS was chosen
because it causes only random point mutations and it has low toxicity and high mutation rates
can be achieved with minimal cell death.
To perform the mutagenesis experiment, JE2 or JE2 HoR cells containing the indicator
plasmid will be grown from a freezer stock. The purity of these cells will be ensured by streaking
cells to single colonies on LB agar with chloramphenicol and grown at 30°C. An isolated colony
would then be picked and grown in LB until mid-log phase (approximately 1x108 CFUs ml-1).
These cells will then be grown in media containing EMS for 1 hour at 30°C. Cells will then be
pelleted and washed in a solution containing sodium thiosulphate to inactivate the EMS. A growout step will then be performed to allow the DNA damage to become mutation, cells will be
grown in fresh LB for 3 to 3.5 hours at 30° C. Mutagenesis will be performed on 4 separate 25
ml cultures in parallel. The mutation of billions of cells in each culture, plus separate parallel
cultures ensures independence of mutants recovered during the screen. Aliquots of these cultures
would then be frozen in 10% glycerol at -80° C for use in the screen.
Prior to performing the mutagenesis some initial testing was needed to determine
mutation rate and toxicity. A concentration resulting in approximately 90% lethality would be
ideal for the high mutation rate in the surviving cells. Mutation rates as high as 5x10-2 per gene
have been reported.
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Screening of mutants
Mutants will be screened by fluorescence-activated cell sorting (FACS). Because the
mutagenized cells would express PIA-independent biofilms, we will be screening for cells with
increased ica expression, indicated by increased gfp expression. The threshold for sorting will be
determined by comparison of JE2/JE2 HoR and JE2 mecA::mar gfp expression. The pooled
mutant cells, both gfp+ and gfp-, will be conserved and their genomic DNA will be extracted by
a phenol:chloroform extraction method or a bacterial DNA extraction kit. We plan to collect
approximately 400 mutants.

Analysis of data
The pooled DNA of the collected mutants will be sequenced by next-gen Illumina
sequencing. We will want at least 10X coverage of each mutant (both the gfp+ and much smaller
gfp- pools). The gfp+ pool would have mutations in genes involved in ica repression, sequencing
of the gfp- mutants would control for ancestral mutations and mutation hot spots. The raw data
output from the Illumina sequencing is FASTQ format. This format gives the data for each read,
including the sequence and a rating of confidence in each base. First, the reads will be mapped to
a reference sequence. This reference sequence would be the sequence of JE2 in FASTA format.
The program would perform an alignment and map each read to a specific location of the
genome. Next, because we are only interested in mutations that occurred within an open reading
frame a GTF file will be used to filter out all other mutations.
These data will then be tabulated for ease of analysis. The table is planned to contain 4
columns – gene number, number of mutations in gfp+, number of mutations in gfp-, and gene
size in bp. There would be a total of 2604 rows – one for each gene. Synonymous mutations,
17

those which do not affect the protein product, would be removed from the mutation count. Next,
the computer will analyze the number of mutations in each gene for the gfp+ and gfp- groups.
Any gene with a statistically significant difference will be tagged for additional analysis. For
closer analysis of each of these genes a separate file would be prepared for each. These files will
give more details on the types of mutations that occurred. This file will also be in the form of a
table and will list each mutation, its counts (number of reads) in each pool, nucleotide position,
and amino acid change. We will then consult published literature for what is known about these
genes and see if any known function gives insight into how they might function in the regulatory
mechanisms of S. aureus biofilm production. If no known function has been assigned to these
genes we would then search the sequence in BLAST to look for similar genes in other organisms
that would give us insights into its functions. We would expect to see many mutations within the
mecA gene. This will serve as a positive control for the experiment.

Site-specific knockouts of genes of interest
To confirm the role of any gene of interest found in the analysis of the mutant pool site
specific mutagenesis will be done to knock out the gene. There are two strategies we could
employ to do this, the choice of which would depend on whether we wanted to create the
knockout in JE2 or JE2 HoR. For creation of knockouts in JE2 the process is likely already
complete. The Nebraska transposon mutant library, available through BEI, contains transposon
insertions in nearly all non-essential genes in JE2. We would simply need to order the mutant we
want and assess its biofilm type.
If the gene of interest were unavailable in the transposon mutant library, or if we would
like to create a knockout in JE2 HoR, we would need to cause a knockout through homologous
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recombination. For this task we would be able to use the same plasmid, pJB38, that we used for
the reporter plasmid. Instead of inserting the ica/gfp fusion we would instead clone a segment of
the gene of interest. This region of homology will occasionally cause spontaneous
recombination. These cells would be isolated by growing the transformed cells at 37°C. At this
temperature the plasmid will be unable to replicate unless it has been integrated, through
recombination, into the genome. The biofilm type would then be determined to assess the gene’s
impact on biofilm regulation.

Project 1 Results
Characterization of Strains
The wild-type strain used in this study was JE2, the plasmid-free variant of USA 300
LAC. The MRSA characteristics of this strain were verified through PCR amplification of the
mecA gene and growth on LB agar containing 4 μg/ml oxacillin [62]. This strain was the wildtype HeR strain used in this study. A JE2 mutant with a transposon insertion in the mecA gene
was used in this study as the representative MSSA strain. It was obtained from the Nebraska
Transposon Mutant Library (NTML) [59]. This strain, JE2 mecA::mar, was verified to have a
disruption in the mecA gene by its inability to grow on LB agar containing 4 μg/ml oxacillin
[62]. For the purposes of this study a HoR strain was also needed. We created the strain JE2 HoR
through spontaneous mutation by selecting for mutants able to grow on LB agar containing 100
µg/ml oxacillin as described by Pozzi et al. (see Figure 4 A) [5]. JE2 HoR was slower growing
than JE2, even when both were grown on LB agar without antibiotic. JE2 HoR required two days
of growth for colonies to be similar in size to JE2 colonies after a single day.
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Also used extensively in this study were two strains important in the transformation
process. Escherichia coli DH5α and S. aureus RN4220. The uses of these strains will be
described in the section on cloning.

Assessment of the biofilm phenotypes of test strains
It was necessary to verify that the test strains used in this study exhibited the typical
biofilm characteristics which had been observed by other researchers. That is, a PIA-dependent
phenotype in the MSSA strain (JE2 mecA::mar), a PIA-dependent to intermediate phenotype in
the heterogeneously resistant strain (JE2 HeR), and a PIA-independent phenotype in the
homogenously resistant strain (JE2 HoR) [5, 38, 41, 43, 52, 54]. This was done through a biofilm
staining assay in which biofilms were grown in 96-well plates, treated with a substance that
would preferentially disrupt one biofilm type over another, and then stained do determine the
degree to which biofilms were affected by the treatments (see figure 8) [5, 38, 47, 63, 64]. In this
study, both proteinase K and DNase were used to indicate a PIA-independent biofilm through the
disruption of extracellular DNA or proteins. Sodium meta-periodate, which disrupts
polysaccharides through oxidation, is used for the identification of a PIA-dependent biofilm.
JE2, JE2 HoR, and JE2 mecA::mar were all tested for biofilm composition. Once stained
the biofilms in the wells were inspected visually, and by optical density using a plate reader, for
significant reduction in biofilm mass. JE2 saw moderate reduction in biofilm mass after
treatment by both proteinase K and DNase, though the reduction by proteinase K was greater,
consistent with the intermediate biofilm phenotype that it might be expected to express. JE2 HoR
was highly affected by both proteinase K and DNase, demonstrating the expected PIA-
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independent phenotype. JE2 mecA::mar was affected little by both proteinase K and DNase,
consistent with the expected PIA-dependent phenotype.
We had planned to use the sodium meta-periodate assay as well as the enzymatic tests to
determine the biofilm phenotypes of the test strains, but we were never able to fully develop this
assay before this project was put on hold. We were never able to successfully break down PIAdependent biofilms with sodium meta-periodate treatment. What we often saw, instead, was an
increase in staining by crystal violet over the control. We suspect that there may be a chemical
enhancement of the binding of crystal violet to the biofilm caused by the sodium meta-periodate.
Due to the labor-intensive nature of the 96-well plate method for biofilm analysis we
wanted to develop a faster and easier assay to determine biofilm phenotype. We used Congo red
agar, which has been shown to stain the amyloid fibrils of the extracellular matrix [65, 66]. After
various modifications of the media formulation we were able to see slight differences in color
between biofilm phenotypes (see Figure 4B). Due to the subtlety of this difference we weren’t
able to use this assay to reliably determine the phenotype.
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Figure 4 – Results from project 1
A: No growth of JE2 (left) vs normal growth of JE2 HoR (right) on LB agar with 100 μg/ml of oxacillin.
B: Biofilm phenotype demonstrated on Congo red agar. Left is JE2 mecA::mar displaying slightly lighter
colored colonies compared to JE2 HoR on the right. Difference was too subtle to use this method for a
screen. C: An agarose gel showing the various products produced by overlap extension PCR. The boxed
band is the desired 1866 bp product.
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Mutagen titration
The mutagen ethyl methanesulfonate (EMS) was titrated to determine appropriate
concentrations for the mutagenesis experiments. We expected a concentration of EMS with a
lethality of approximately 90% would be appropriate for our mutagenesis experiments. We
estimated the appropriate concentration of EMS to be between 0.25% and 1%. EMS was added
to log-phase cells at the appropriate concentrations and incubated for 1 hour. Cells were
centrifuged and the pellet was washed and resuspended. A serial dilution was then performed
and cells were plated to compare to an un-treated control. 0.5% EMS was found to give
approximately 90% lethality.

Transformation of S. aureus
S. aureus is known for being difficult to transform. Our lab had no experience
transforming S. aureus, so we needed to develop a reliable transformation protocol. S. aureus
transformation is a two-step transformation. After a construct is created in E. coli the S. aureus
strain RN4220 is transformed by electroporation. RN4220 lacks the mechanisms that would
normally destroy incorrectly methylated DNA (e.g. DNA originating in E. coli). The incoming
plasmid will receive proper methylation in RN4220 from which it can be transformed into the
final recipient strain.
Our final protocol was developed from a general protocol for S. aureus electroporation
and modified through trial and error until it gave reliable results. We were able to take plasmids
from E. coli, through RN4220, and into JE2, the final recipient. These transformants were
confirmed by antibiotic selection and plasmid extraction.
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Cloning of the reporter plasmid
The cloning of a reporter plasmid to indicate the expression of the ica operon began with
the synthesis of the upstream promoter region of the operon linked with gfp through overlapextension PCR. This was a three-step process with the first two steps being the cloning of the
two genetic elements to be fused with the addition of restriction sites and overlap region and the
third step being the fusion through overlap extension. The ica promoter region and icaR gene
was cloned from JE2 genomic DNA with an EcoRI restriction site added at the 5’ end and the
EF-TU Shine-Dalgarno sequence (which doubled as the overlap between the two PCR products)
added at the 3’ end. The second product was the gfp gene, cloned from the plasmid pGFP-F
acquired from the Nebraska Transposon Mutant Library, a superfolder GFP proven to be
functional in S. aureus [59]. Primers were used to add the EF-TU Shine-Dalgarno sequence to
the 5’ end of this product and a KpnI restriction site to the 3’ end. Both components were cloned
without issue, but we encountered difficulty performing the final fusion step. When the PCR
product was imaged by electrophoresis the correct molecular weight band of the final product
was visible. Lower and higher molecular weight bands were visible as well (see Figure 4 C).
After excision and cleanup and restriction digest we attempted to ligate the product into pJB38,
but this yielded no transformants. We also attempted the process without first excising the band
of interest to simplify the process, but once again were unable to recover any transformants.
Due to the lack of progress in this cloning project, we decided to start over with a new
strategy. We would use lacZ instead of gfp to simplify the screen and we would clone the ica
promoter region and lacZ separately. These would be ligated into pJB38 individually, removing
the overlap extension step. The ica promoter region would be cloned to include an EcoRI
restriction site at the 5’ end and the EF-TU shine-dalgarno sequence and a KpnI restriction site at
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the 3’ end with a total product size of 1134 bp. This was cloned without issue and successfully
ligated into pJB38. We designated this new plasmid pICA Next, lacZ was cloned from pUC19
with an existing SmaI restriction site used at the 5’ end and the addition of a SalI restriction site
at the 3’ end giving a product of 400 bp. The 3’ restriction site of the ica product and the 5’
restriction site of the lacZ product did not match to keep lacZ in frame with the start codon and
Shine-Dalgarno of EF-TU from the ica product. This product was successfully cloned from
pUC19, but we were unable to ligate it into pICA. We were never able to recover any
transformants. Many different methods of preparation, including CIP treatment of the insert, as
well as various incubation times and temperatures were tried, but we were never able to
successfully insert lacZ into pICA. During these set-backs we observed other interesting
characteristics of S. aureus biofilms while testing our collections of hospital-associated and
meat-associated strains. We decided to put this project on hold while we pursued a second
project.

Project 1 Discussion
Though the goals of this project have not yet been met, most of the tools necessary to
complete this project have been developed and it may yet be completed by future students. This
project has also provided, for our lab, foundational tools which will likely be used in future S.
aureus research projects. This includes our familiarization with the genetic tools available for S.
aureus, the development of a reliable transformation protocol for S. aureus, and refinement of
biofilm dispersal and staining assays. Additionally, the plasmid pICA may be a powerful tool for
future biofilm regulation studies. It is perfectly situated for the addition of any number of genes
for control by the ica operon, reporter or otherwise.
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The final difficulty that forced us to pause work on this project was the inability to insert
the lacZ fragment into pICA. We initially suspected that the ligation issues could be due to the
use of SmaI, which produces blunt ends, causing the insert fragments to fuse together. We added
an alkaline phosphatase (CIP) treatment to our procedures to prevent insert to insert fusions, but
there was no change in outcome. Control plasmids that had been digested only did not yield
transformants, while those that were digested and re-ligated did. One explanation for our
inability to insert lacZ would be a restriction site disrupting mutation in pICA, pUC19, or the
cloned lacZ fragment. In future work, the cloning process could be started over to solve a
mutation issue. Alternatively, the entire cloning process could be redesigned to remove any
unknown issues in the cloning design.

Project 2 – Staphylococcus aureus isolated from retail meats forms biofilms of composition and
mass distinct from strains associated with disease in humans
Background
Due to difficulties in cloning the reporter plasmid as had originally been planned, a new
project was begun to analyze some of the biofilm characteristics we had observed during the first
project. We would use some of the same techniques that we had already been using to analyze
the biofilm characteristics of our collections of hospital-associated and meat-associated strains
which we had collected in the course of other related projects.
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Meat-associated S. aureus collection
Our collection of meat-associated S. aureus isolates are all environmental isolates
collected by our lab and include 32 strains, of which 11 are MSSA and 21 are MRSA. They were
collected from samples of retail meat products purchased from 11 different retailers in the state
of Utah and includes samples from a variety of meat types including beef, pork, chicken, and
turkey. The breakdown of these strains, their origins, and resistance-profile is shown in Table 1.
These isolates were confirmed as S. aureus through rigorous identity testing that included growth
and fermentation on mannitol salt agar (MSA), gram staining, and catalase and coagulase testing
[67, 68]. Isolates that had passed these tests were confirmed S. aureus through PCR
amplification of the S. aureus 16S rRNA and nuncA genes [69]. Additionally, these strains were
identified as MRSA or MSSA through their ability to grow in media containing 2 µg/ml of
oxacillin and through PCR amplification of the mecA gene [69].
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Table 1 – List of S. aureus strains used in project 2
Meat-associated strains are shown on the left, hospital-associated strains are shown on the right. A total of
32 meat-associated strains were studied (21 MRSA, 11 MSSA) and a total of 22 hospital-associated
strains were studied (15 MRSA, 7 MSSA). Strain names: C strains are chicken origin, P are pork, T are
turkey, and B are beef.
Strain
name
C1
C2
C3
C7
C11
C15
C20
C4
C6
C9
C10
P3
P4
P5
P6
P11
P14
P7
P9
P10
P12
P13
T2
T4
T5
T6
T7
T10
T14
T12
T13
B8

Type

Source

MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MSSA
MSSA
MSSA
MSSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MSSA
MSSA
MSSA
MSSA
MSSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MSSA
MSSA
MRSA

Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw chicken
Raw pork
Raw pork
Raw pork
Raw pork
Raw pork
Raw pork
Raw pork
Raw pork
Raw pork
Raw pork
Raw pork
Raw turkey
Raw turkey
Raw turkey
Raw turkey
Raw turkey
Raw turkey
Raw turkey
Raw turkey
Raw turkey
Raw Beef

Strain name
HA 1
HA 2
HA 3
HA 4
HA 5
FR1913
USA 300 LAC
HFH 30364
NY336
CO34
GA92
TN112
CA127
USA 400
USA 300-0114
SH 1000
SA 6538
SA 29213
SA 25923
SA 43300
SA 4651
SA 12600

Type
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MRSA
MSSA
MSSA
MSSA
MSSA
MSSA
MSSA
MSSA

Source
Hospital pathology lab
Hospital pathology lab
Hospital pathology lab
Hospital pathology lab
Hospital pathology lab
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
Culture collection
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Hospital-associated S. aureus collection
Our collection of hospital-associated S. aureus consists of 22 strains acquired through
culture collections and verified MRSA strains acquired through a contact in a hospital pathology
department. This collection of hospital-associated strains consists of 15 MRSAs and 7 MSSAs;
see Table 1.

Hypothesis
We hypothesized that the biofilm characteristics of these two S. aureus populations
would be different, that is, that we would see distinct trends in overall biofilm mass and
composition for both hospital-associated and meat-associated strains. While the origin of the
strains that contaminate retail meat-products is not well understood, there is some evidence to
suggest that they are of livestock origin [70-73]. Livestock-associated strains are, in general,
genetically distinct from their human-derived counterparts, though there is occasional
transmission from one population to the other [74-76]. Demonstrating general phenotypic
differences between the biofilms formed by meat-associated strains and hospital associated
strains would provide additional evidence that meat-associated strains do not generally originate
from a human source. These findings would also have implications for our understanding of the
virulence potential of these strains.
We also hypothesized that we would see differences in the biofilm characteristics of
MRSA strains and MSSA. Research has shown a correlation between oxacillin susceptibility and
biofilm composition. Highly-resistant MRSA strains tend to have proteinaceous biofilms while
less-resistant MRSAs and MSSAs tend to have polysaccharide-based biofilms [5, 38, 40]. We
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expected to see these differences in our collection of MRSA strains and MSSA strains from
hospital and meat sources.

Experimental design
Evaluation of biofilm characteristics was performed in a 96-well plate based assay
wherein biofilms were allowed to grow and adhere to the bottom of each well. Biofilms were
then stained by filling each well with 0.1% crystal violet, washing, and then eluting stain from
the biofilm as a measure of total organic mass accumulated over the growth period. This was
performed in quadruplicate for each strain. Composition was measured through treatment with
biofilm-disrupting substances before staining. Dispersal by proteinase K was used to indicate a
reliance on extracellular proteins for biofilm structural integrity; DNase demonstrated eDNA as
an essential structural component; and sodium meta-periodate, which degrades polysaccharides
demonstrated structural dependence on PIA. Together, degradation by proteinase K and DNase
indicate a PIA-independent (protein) biofilm type, whereas degradation by sodium metaperiodate would indicate a PIA-dependent (polysaccharide) biofilm type. Because SA biofilms
exist in a spectrum of compositions and PIA-dependent and PIA-independent are only general
categories, quantitative measurements of enzymatic or chemical impact on biofilm mass was
taken by measuring the absorbance of eluted crystal violet at 595 nm. This information was used
to show general trends for each SA category as well as show quantitative data for each individual
strain.
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Project 2 Results
The first characteristic that we analyzed was over-all biofilm mass formed by hospitalassociated and meat-associated strains. Biofilm mass, as measured by crystal violet staining of
biofilms formed over 24 hours of growth, includes both the cells of the biofilm as well as the
extracellular matrix. The positively charged crystal violet binds to the negative charges of DNA
and proteins. After cells had been grown without shaking for 24 hours in the wells of 96-well
plates, the biofilms were fixed, stained, and the stain was eluted using organic solvents. The
absorbance was measured at 595 nm to give a quantitative measure of biofilm mass.
Biofilm mass was found to vary considerably from strain to strain. Some strains, such as
P13 or C15 (see Figure 5A) had very little biofilm formation, while others like HA1 or SH 1000,
for example, had considerable biofilm accumulation (see Figure 5B). Both categories, meatassociated strains and hospital-associated strains, had strong biofilm formers and weak biofilm
formers. The averages between these categories, however, were different. The average OD 595
reading for meat strains was found to be 0.887 while the average for hospital strains was 1.286
with a p value for these averages of 7.09x10-3 (two-sample T-test assuming equal variances) (see
figure 5C).
Next, we examined the susceptibility of the biofilms formed by each strain to degradation
by proteinase K. A biofilm broken down by proteinase K depends on proteins, either attached to
the cell surface or in the extracellular matrix, for structural integrity of the biofilm. After
biofilms had been grown for 24 hours in a 96-well plate, planktonic cells were gently washed
from the wells and a solution containing proteinase K, or a mock treatment, was added to each
well. The mock treatment consisted of the appropriate buffer without the enzyme. After
incubation at 37° C for two hours the wells were gently washed and the biofilms were fixed and
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Figure 5 – Biofilm mass measured by OD
Shown is the OD 595 of crystal violet eluted from biofilms formed within the wells of a 96 well plate.
Darker colored bars represent MRSA strains, light colored bars represent MSSA strains. Error bars show
the standard error of the 4 replicates for each strain. A: Biofilm mass of meat-associated strains. B:
Biofilm mass of hospital associated strains. C: Average biofilm mass of each category, error bars show
standard error, p = 7.0x10-3.
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stained. The stain was then eluted and OD was measured at 595 nm. To make valid comparisons
between strains with high biofilm-mass and those with lower biofilm-mass the effect of the
enzyme was measured as a percent reduction of biofilm mass calculated as the percent difference
between mock treated and treated.
Both hospital-associated and meat-associated strains had some strains which were highlyaffected by proteinase K (such as P5 or HA2) and some strains which were unaffected (such as
C5 or SA 25923) (see figure 6 A and B). We did not observe a correlation between biofilm mass
and proteinase K susceptibility. We did, however, observe a significant difference in proteinase
K susceptibility between hospital-associated and meat-associated strains. The average reduction
of meat strains was 33.24% while the average reduction in hospital strains was 52.01% with a p
value for these averages of 8.09x10-4 (two-sample T-test assuming equal variances)(see figure 6
C).
Next, we measured biofilm susceptibility to degradation by DNase. As before, each strain
was grown in the wells of a 96-well plate and a biofilm was allowed to form for 24 hours.
Planktonic cells were gently washed away and the biofilm was treated with a solution containing
DNase (or a mock treatment) for 2 hours before a final wash, fixing of the biofilm, and staining.
Degradation by DNase shows reliance on extracellular DNA for the structural integrity of the
biofilm. Biofilm stain was eluted and OD 595 measured. The OD reading of the treated biofilm
was subtracted from that of the mock treated and the difference was given as a percentage to
normalize the data so as to compare robust biofilm forming strains with weak biofilm forming
strains.
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Figure 6 – Percent biofilm reduction by proteinase K
Percent reduction measured by percent change in OD 595 from mock treatment. Error bars show standard
error for difference. A: Percent reduction by proteinase K for meat-associated strains. Dark bars are
MRSA strains, lighter bars are MSSA strains. B: Percent reduction by proteinase K for hospitalassociated strains. Dark bars are MRSA strains, lighter bars are MSSA strains. C: Average percent
reduction for each category, p = 8.1x10-4
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We observed that, like proteinase K susceptibility, meat-associated and hospitalassociated strains had a mix of highly-affected strains (C20 and SA 43300) and unaffected
strains (P10 and HA1) (see figure 7 A and B). We observed no correlation between biofilm mass
and DNase susceptibility. However, there was a significant difference between the DNase
susceptibility of hospital-associated and meat-associated strains. The average percent reduction
in biofilm mass DNase for meat-associated strains was 47.90% and the average for hospitalassociated strains was 35.93% with a p value of 3.38x10-3 (two-sample T-test assuming equal
variances) (see figure 7 C).
We also compared each of these characteristics among MRSA strains and MSSA strains
for each category (biofilm mass, proteinase K susceptibility, and DNase susceptibility) and found
no significant differences. Differences were only observed when comparing strains from
different sources. These characteristics had no observable relation to oxacillin resistance.

35

A

B

C

p= 3.4x10
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Figure 7 – Percent biofilm reduction by DNase
Percent reduction measured by percent change in OD 595 from mock treatment. Error bars show standard
error for difference. A: Percent reduction by DNase for meat-associated strains. Dark bars are MRSA
strains, lighter bars are MSSA strains. B: Percent reduction by DNase for hospital-associated strains. Dark
bars are MRSA strains, lighter bars are MSSA strains. C: Average percent reduction for each category, p
= 3.4x10-3
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Project 2 Discussion
As we had hypothesized, we saw many differences between hospital-associated and
meat-associated strains. This reinforces previous research showing that meat-associated S.
aureus typically originates from an animal source since animal strains and human strains are
genetically distinct populations. Hospital strains, on average, formed more robust biofilms with
an average OD reading of 1.286 while meat strains had an average OD reading of 0.887
(p=7.09x10-3). These differences are likely the result of selective pressures found in the
environments to which they have adapted. Since all our hospital strains were isolated from active
infections, this relationship may be influenced by the fact that biofilms are such an important
virulence factor and any strain able to invade a host and establish an infection is more likely to
have a strong biofilm-forming capacity. There may be other selective pressures in the hospital
environment that cause hospital-associated strains to have more robust biofilms such as adaption
to hard plastic surfaces, a defense against cleaning agents, or to provide some resistance to
antibiotics as has been shown in prior research [34]. On the other hand, if meat-associated strains
come from an animal source as research has suggested, they will be adapted to an entirely
different environment [70-73]. We can assume that this environment would be much dirtier, that
these strains will be subjected to different drug-challenges, and that they may be commensal.
The differences in biofilm composition between hospital-associated and meat-associated
were the most surprising results. While we had expected to see compositional differences
between the two strain categories, we hadn’t expected proteinase K susceptibility and DNase
susceptibility to be independent of one another. The average reduction of meat strain biofilms by
proteinase K was 33.24% while that of hospital strains was 52.01% (p=8.09x10-4) and the
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average reduction of meat-associated strain biofilms by DNase was 47.9% while that of hospital
strains was 35.93% (p=3.38x10-3).
Because proteinase K affected hospital strains greater than meat strains and DNase
affected meat strains greater than hospital strains we can see that these characteristics are not
necessarily connected, as we had hypothesized. While the protein and polysaccharide biofilm
dichotomy may be a useful model when considering the extremes of S. aureus biofilms, it
appears that there is a spectrum of S. aureus biofilm characteristics in between with a mixture of
dependence on protein, eDNA, and polysaccharides for structural integrity of the biofilm. When
PIA-independent (protein) biofilms are described they are typically HoR MRSA strains [5, 38,
41, 43]. If we assembled a collection of HoR strains the relationship between high mecA
expression and decreased ica expression would likely hold true and we would see high
susceptibility to both proteinase K and DNase. When separated into MSSA and MRSA
categories we didn’t see any significant differences in the biofilm mass or composition of our
strains.
Some of the interesting strains that illustrate these findings are highlighted in figures 6
and 7. For example P14 is unaffected by proteinase K, but highly affected by DNase. P10 is the
opposite, it is affected by proteinase K, but DNase has no affect. Other strains, such as SA4651
were reduced by both enzymatic treatments. Interestingly, we didn’t have any strains that were
unaffected by both treatments. This could imply that strains may depend on proteins or eDNA, or
both for structural integrity, but we have not characterized any strains that depend on neither for
biofilm integrity.
In summation, we have found that on average S. aureus hospital-associated strains form
more-robust biofilms than meat-associated strains, hospital-associated strains were more
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susceptible to proteinase K degradation than meat-associated strains, and meat-associated strains
were more susceptible to DNase degradation than hospital-associated strains. This implies the
effect of environmental selective pressures on biofilm formation and composition.
Due to the dangerous nature of S. aureus as a pathogen, continued study of its biofilms is
needed to improve patient outlook and public health. Biofilm mass and composition surely have
great implications for virulence and may help us to understand the danger of common exposure
sources such as raw meats.

Methods
Isolation and identification of S. aureus/MRSA from meat samples
Strains isolated from retail meats were identified as S. aureus through a variety of tests.
First, meat samples were swabbed with sterile swabs or pipetting 10 μl of meat juices and
streaked directly onto Mannitol Salt Agar (MSA) plates (Thermo Scientific, Waltham, MA) and
grown overnight at 37° C. Isolates were assessed for their ability to grow on this media as well as
for their ability to ferment mannitol (indicated by the yellowing of the media around colonies).
Possible MRSA strains were identified by their ability to grow on MSA plates containing 2
μg/ml oxacillin, the standard substitute for methicillin which is no longer used clinically. Gram
stains were performed to confirm that these isolates were gram positive cocci, followed by
catalase and coagulase tests, for which all of our SA/MRSA strains were positive. As a final
confirmation of the identities of these environmental isolates, genotypes were assessed by a
triplex PCR assay to detect Staphylococcus-specific 16S rDNA sequences, the nucA gene which
is specific to S. aureus, and the mecA gene which is specific to MRSA as described by Maes et
al. [69]. See primers in table 2.
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Selection of homogeneously-resistant (HoR) strain
A homogeneously-resistant (HoR) mutant of JE2 was selected through random mutation
selected for on media with high oxacillin concentration. JE2 was grown in LB broth (10 g/l
tryptone, 5 g/l yeast extract, 5 g/l NaCl) containing 2 μg/ml oxacillin overnight. 1 ml of liquid
culture was pelleted and resuspended in 100 μl of LB broth and spread on LB agar (10 g/l
tryptone, 5 g/l yeast extract, 5 g/l NaCl, 12 g/l agar) containing 100 μg/ml oxacillin and
incubated overnight at 37° C. JE2 HoR was selected from these colonies and was streaked for
purity before archiving at -80° C in 20% glycerol and used in future experiments.

Mutagen titration
The mutagen ethyl methanesulfonate (EMS) was titrated to determine appropriate
concentrations for SA mutagenesis experiments. We expected a concentration of EMS with a
lethality of approximately 90% would be appropriate for our mutagenesis experiments. We
estimated the appropriate concentration of EMS to be between 0.25% and 1%. Cells were grown
to mid-log phase in LB broth (10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl) at 37° C and 200
rpm shaking, approximately 5 hours and aliquoted into 2.5 ml volumes. EMS was added at
concentrations of 0.25%, 0.5%, 0.75% and 1% and the cells were incubated 1 hour at 30° C and
200 rpm shaking. A lower temperature of 30° C was used to mirror the lower temperature
required when using a temperature-sensitive plasmid in later experiments. Cells were then
pelleted, washed, diluted in increments of factors of 10, and plated. The number of resulting
colonies was counted and compared to an untreated control to determine EMS lethality.
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Biofilm assay
Biofilm mass was measured through an assay in which biofilms were grown and stained
in 96-well plates (see figure 8). Strains to be tested were grown overnight at 37° C in tryptic soy
broth (TSB) (Sigma-Aldrich, St. Louis, MO). Cultures were then diluted 1:200 in 66% TSB with
0.5% glucose added. 200 μl of culture dilution were added to the wells of a 96-well, flatbottomed, tissue-culture plate (Corning Incorporated, Corning, NY) in quadruplicate, covered,
and incubated for 24 hours at 37° C. The liquid and non-adhered cells were then removed from
the wells by gently overturning the plate onto paper towels. Each well was then gently washed
with phosphate-buffered saline (PBS) and allowed to dry. Once dry, 205 μl of 100% ethanol was
added to each well to fix the biofilms, incubated for 15 minutes at room temperature, and then
emptied onto a paper towel. Once the ethanol had dried 205 μl of 0.1% crystal violet dye was
added to each well and incubated for 15 minutes at room temperature. The dye was then emptied
as before, by overturning the plate onto paper towels, and three washes with 210 μl of ddH2O
were performed, dumping the water between each wash. Once dry, stain was eluted from the
biofilms with 205 μl of a mixture of 1/3 volume of EtOH with 40 mM HCl and 2/3 volume of
acetone added to each well. The wells were sealed and incubated with this solution for 15
minutes at 37° C with 100 rpm shaking. 80 μl of eluted stain was removed from each well and
transferred to a new plate for reading and the absorbance at 595 nm was measured for each well.
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Figure 8 – 96-well plate biofilm assay
Shown is an example of a biofilm reduction assay as would be performed with proteinase K or DNase.
Strains being tested are organized in columns with four treated wells and four mock treated wells. Various
biofilm characteristics can be observed in this picture. Column 5, for example forms very robust biofilms
that are affected very little by enzyme treatment. Column 4 forms moderately robust biofilms but are
heavily affected by the enzyme treatment. Column 6 forms weak biofilms, but is less affected by the
enzyme treatment.
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Biofilm dispersal assay
Biofilm dispersal assays were performed using a similar method to that described for the
general biofilm assay with an added enzymatic treatment step after the biofilms are first drained
and washed with PBS. 8 wells of each strain are grown, 4 control wells and 4 test wells (see
figure 8). A solution containing the desired enzyme, DNase or proteinase K, is added to each
well and incubated for 2 hours at 37° C. The wells are then drained, washed with PBS, and
allowed to dry before the assay proceeds with ethanol fixation as described for the general
biofilm assay. The DNase solution consists of 140 U/ml DNase in TSB. The proteinase K
solution consists of 100 μg/ml proteinase K in 10 mM Tris-HCl, pH 7.5. The controls for each
treatment were mock treated with the respective solution without the enzyme. Percent difference
in absorbance at 595 nm was used as a measurement of biofilm dispersal by these enzymes.

Cloning of lacZ and the ica promoter region
Both lacZ and the ica promoter region were cloned by PCR using primers to add
restriction sites and the EF-TU Shine-Dalgarno sequence. For lacZ, pUC19 plasmid DNA was
used as the source of the gene. A PCR program of 94° C for 5 minutes, 40 cycles of 94° C for 30
seconds, 59° C for one minute, and 72° C for one minute, followed by a final extension of 72° C
for 10 minutes was used with the primers for lacZ (see table 2), yielding a product of 400 bp.
The ica promoter region was amplified from JE2 genomic DNA using a PCR program consisting
of 94° C for 7 minutes with 40 cycles of 94° C for 30 seconds, 55° C for 30 seconds, and 72° C
for one minute, followed by a final extension at 72° C for 10 minutes with the primers for icalacZ ica (see table 2), yielding a product of 1134 bp.
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Table 2 – Primers used in project 1 and project 2
lacZ for ica-lacZ
Forward

5’-GCGGTCGACGACGGTGAAAACCTCTGACACA-3’

Reverse

5’-TGTGTGGAATTGTGAGCGGAT-3’

ica for ica-lacZ
Forward

5’-CGCGAATTCCAGGGGAACATTACACTTTTATAA-3’

Reverse

5’-GCGGGTACCCATTATAAAATCTCTCCTACAGGCTTCTTGTTCAATGAA-3’

ica for ica-gfp (overlap extension)
5’-CGCGAATTCCAGGGGAACATTACACTTTTATAA-3’
Forward
(out)
5’-CATTATAAAATCTCTCCTACAGGCTTCTTGTTCAATGAA-3’
Reverse
(in)
gfp for ica-gfp (overlap extension)

Forward
(in)
Reverse
(out)
mecA

5’-AACTAGGAGAGATTTTATAATGCCCGGGAGCAAAGG-3’

Forward

5’-AAAATCGATGGTAAAGGTTGGC-3’

Reverse

5’-AGTTCTGCAGTACCGGATTTGC-3’

5’-GCGGGTACCTTATTTGTAGAGCTCATCCATG-3’

16S rDNA
Forward

5’-GCGGATCCTGACTGCAGTGCCAGCAGCCGCGGTAA-3’

Reverse

5’-GCGGATCCGCGGCCGCGGACTACCAGGGTATCTAAT-3’

nucA
Forward

5’-GCGATTGATGGTGATACGGTT-3’

Reverse

5’-AGCCAAGCCTTGACGAACTAAAGC-3’
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Overlap extension PCR
An overlap-extension PCR technique was used to first amplify and then splice the ica
promoter region and gfp. The ica promoter region was amplified from JE2 genomic DNA with
the primers for ica (forward out and reverse in) (see table 2) and a program consisting of 94° C
for 5 minutes followed by 20 cycles of 94° C for 30 seconds, 38.9° C for 30 seconds, and 72° C
for one minute, followed by a final extension of 72° C for 10 minutes. gfp was amplified from
the plasmid pGFP-F with the primers for gfp (forward in and reverse out) (see table 2) and a
program consisting of 94° C for 5 minutes followed by 20 cycles of 94° C for 30 seconds, 46.9°
C for 30 seconds, and 72° C for one minute, followed by a final extension of 72 ° C for 10
minutes. 5 μl of each of these reactions was added to a new PCR reaction tube and run at 94° C
for 5 minutes followed by 15 cycles of 94° C for 30 seconds, 38.9° C for 30 seconds, and 72° C
for one minute and once finished 2 μl of both the primers For_out and Rev_out were added to the
reaction which was then run 30 cycles consisting of 94° C for 5 minutes followed by 30 cycles of
94° C for 30 seconds, 46.9° C for 30 seconds, and 72° C for one minute, followed by a final
extension at 72° C for 10 minutes. The product of 1137 bp was visualized on and excised from a
1% agarose gel and cleaned up using the Zymoclean™ Gel DNA Recovery Kit by Zymo
Research.

Recovery of DNA from agarose gels
We used the Zymoclean™ Gel DNA Recovery Kit from Zymo Research for purification
of DNA from agarose gels and followed the protocols provided by the manufacturer.
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Plasmid Mini-prep
Plasmid mini-preps were performed using the E.Z.N.A® Plasmid DNA Mini Kit I from
Omega Bio-Tek. The protocols provided for this kit by the manufacturer were followed.

Genomic DNA extraction
Genomic DNA extraction was performed using the E.Z.N.A.® Bacterial DNA Kit from
Omega Bio-Tek. We followed the protocols provided by the manufacturer for this kit.

Restriction digest and CIP treatment
The restriction enzymes used were purchased from New England Biolabs. The restriction
enzymes EcoRI-HF, KpnI-HF, SmaI, and SalI-HF were used. We followed the manufacturer’s
instructions and used the provided buffer for digestion. All digestions were performed at 37° C
with the exception of SmaI which is active at 25° C.
We acquired our Calf Intestinal alkaline phosphatase (CIP) from New England Biolabs.
When CIP treatment was included, the manufacturer’s instructions were followed. The
phosphatase was added directly to the digestion reaction and incubated for 30 minutes at 37° C,
the DNA was then purified by spin column prior to ligation.

DNA cleanup and purification
Prior to ligation, DNA was purified using the E.Z.N.A Cycle Pure Kit by Omega BioTek. The protocols provided by the manufacturer for this kit were followed.
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Ligation
T4 DNA ligase from Thermo scientific was used for ligations. 20 μl reactions were
performed which included 2 µl of 10X DNA ligase buffer, 1 µl of DNA ligase, and the
remaining volume consisting of ddH2O, vector DNA, and insert DNA. Several different
concentrations of vector DNA and insert DNA were used in the troubleshooting of this step. The
reaction mixture was incubated for 2 hrs at room temperature or overnight at 16° C.

Preparation of chemically competent E. coli cells
An overnight culture of E. coli DH5α is used to inoculate a flask with 50 ml of LB broth
and grown to logarithmic phase. The culture is pelleted at 8000 rpm for 5 min and resuspended
in ice-cold 30 mM CaCl2. Cells are distributed by 0.5 ml into microcentrifuge tubes (all kept on
ice) and pelleted at 30 seconds at 10,000 g. Each pellet is resuspended in 0.5 ml ice-cold CaCl2
and flicked to mix. 50 µl volumes were then distributed into pre-chilled microcentrifuge tubes
and immediately frozen at -80° C.

Transformation of E. coli
E. coli DH5α was used as the recipient cells for our transformations of E. coli. Cells are
thawed on ice for 20 minutes, 1-5 µl of DNA is then added to the bottom of a 15 ml conical
centrifuge tube and the thawed E. coli cells are added to the tube and incubated on ice for 20
minutes. Tubes are then transferred directly from the ice to a water bath at 42° C and incubated
for 90 seconds and then placed back on ice for two minutes. 250 µl of LB broth is then added to
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the tube and incubated at 37° C in the shaking incubator for 45 minutes. Cells were then plated
on selective media and allowed to grow overnight at 37° C.

Preparation of electrocompetent S. aureus cells
10 ml of overnight culture is added to 90 ml of LB media and grown to OD578 = 0.6.
Two 50 ml centrifuge tubes are filled with bacterial culture and placed on ice for 15 minutes.
They are then centrifuged at 4000 rpm for 7 minutes at 4° C. Each is then washed with 50 ml icecold sterile water and again centrifuged as before and washed one more time with 50 ml of icecold sterile water and centrifuged as before. The cells are then washed with 16 ml of ice-cold
sterile water and pelleted at 4000 rpm for 5 minutes at 4° C. Cells are then washed with 2 ml icecold sterile 10 % glycerol and centrifuged at 4000 rpm for 3 minutes at 4° C. Cells are then
washed with 1 ml of ice-cold 10% glycerol and pelleted at 4000 rpm for 3 minutes at 4° C. The
cells are then resuspended in 700 µl of ice-cold 10% glycerol and immediately frozen in 70µl
aliquots at -80° C.

S. aureus transformation by electroporation
Electrocompetent S. aureus cells are thawed on ice for approximately 5 minutes and then
incubated at room temperature for 10 minutes. Cells are pelleted at 10,000 rpm for 5 minutes and
resuspended in 500 µl of EC buffer (0.5 M sucrose and 10% glycerol). Cells are pelleted at
10,000 rpm for 5 minutes and resuspended in 85 µl of EC buffer. 5-15 µl of DNA is then added
and gently mixed. Mixture is transferred to a 1 mm gap electroporation cuvette and pulsed twice
manually, with approximately 1 second between pulses, at 2.4 kv using a Bio-Rad MicroPulser
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electroporator. Immediately add 900 µl of LB media and transfer to a culture tube. Incubate at
30° C (for temperature sensitive plasmid) for 2 hours and then spread on selective media and
grow overnight at 30° C.
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